A New IV Catheter Device Featuring Automatic and Integrated Blood Sampling
<strong>Technology</strong><br>
We offer a new IV catheter for the use during emergency and disasters to automatically preserve a pre-infusion blood sample from every patient.<br><br> The new catheter system is based on existing IV devices. Its new features include an integrated blood sampling reservoir that is fixed to the IV catheter via a flexible plastic band and remains attached to the patient following selffilling with a small blood volume until admission in the hospital. In addition, identifiers are provided comprising a housing identifier at the IV catheter and a reservoir identifier. Both identifiers have codes assigned to one another. The identifier system may comprise an electronic memory medium, in particular an RFID chip or barcode that can be read out. Upon arrival, the reservoir is disconnected from the patient and immediately sent to the laboratory for blood group typing. A prototype has been produced by injection molding process.<br><br> It has been demonstrated in a prospective phase II study that the device ensures rapid and precise blood typing in 100% of emergency patients showing that the new catheter design offered a significant advantage over the standard catheter. Furthermore, the new device increases patient safety by securing this precious very first blood sample in every case in addition to the sample taken from a central line inserted inside the hospital. Thereby two independently drawn specimens are available for ABO-typing even in circumstances with extreme time constraints.<br><br> <strong>Benefits</strong><br> <ul type=“disc“> <li>Increased patient safety</li> <li>Rapid and precise ABO typing</li> <li>Redundant patient to blood product identification for increased general transfusion safety</li> <li>No interference with routine procedures</li> <li>Prevention of excessive use of 0 negative blood resources, thus allowing further cost reduction</li> </ul> <p><strong>IP Rights</strong><br> DE102004055989B4 and DE102009018837B4 granted<br> EP and US patent pending <br> (Priority Nov 2004) <br><br> <strong>Patent Owner</strong><br> Charité – Universitätsmedizin Berlin
Weitere Informationen: PDF
ipal GmbH
Tel.: +49 (0)30/2125-4820
Ansprechpartner
Dr. Dirk Dantz
Media Contact
Alle Nachrichten aus der Kategorie: Technologieangebote
Neueste Beiträge
Klimawandel führt zu mehr alpinen Gefahren
Von Steinschlag bis Eislawine: So hat der Klimawandel die Naturgefahren in den Alpen verändert. Der Klimawandel intensiviert vielerorts Naturgefahren in den Bergen und stellt den Alpenraum damit vor besondere Herausforderungen….
SAFECAR-ML: Künstliche Intelligenz beschleunigt die Fahrzeugentwicklung
Mit neuen Methoden des Maschinellen Lernens gelingt es, Daten aus der Crashtest-Entwicklung besser zu verstehen und zu verarbeiten. Im Projekt SAFECAR-ML entsteht eine automatisierte Lösung zur Dokumentation virtueller Crashtests, die…
Robotergestütztes Laserverfahren ermöglicht schonende Kraniotomie im Wachzustand
Um während neurochirurgischen Eingriffen komplexe Hirnfunktionen testen zu können, werden diese an wachen, lokal anästhesierten Patienten durchgeführt. So können die Chirurgen mit ihnen interagieren und prüfen, wie sich ihr Eingriff…